Kakinuma S, Suzuki K, Hatori M, Saitoh K, Hasegawa T, Furumai T, Oki T
Bristol-Myers Squibb Research Institute, Tokyo, Japan.
J Antibiot (Tokyo). 1993 Mar;46(3):430-40. doi: 10.7164/antibiotics.46.430.
The biosynthetic pathway of the pradimicin-benanomicin family of antibiotics was investigated by using sinefungin and blocked mutants derived from Actinomadura verrucosospora subsp. neohibisca E-40 (a high pradimicin producer) or Actinomadura sp. AB1236 (a benanomicin producer). Addition of sinefungin to strain E-40, pradimicin A aglycone-producing mutant or strain AB1236 inhibited the formation of 11-O-demethyl-7-methoxypradinone II (11dM-7M-PN II), resulting in the accumulation of 11-O-demethylpradimicinone II and pradimicinone II. By feeding pradimicin A aglycone and its analogs to mutants blocked early in pradimicin or benanomicin biosynthesis, the following results were obtained: 11-O-demethylpradinone II, 11dM-7M-PN II 11-O-demethylpradinone I, 11-O-demethylpradimicinone I and pradimicinone I were converted to pradimicin A or benanomicin A; the remaining 6 aglycone analogs were not incorporated into the antibiotics. Pradimicin B, dexylosylpradimicin C and dexylosylbenanomicin A were converted to pradimicin A, pradimicin C and benanomicin A, respectively. A biosynthetic pathway for the antibiotics is proposed.
通过使用西奈芬净以及源自疣孢马杜拉放线菌新木槿亚种E - 40(一种高产普拉地米星的菌株)或马杜拉放线菌AB1236(一种产贝纳诺霉素的菌株)的阻断突变体,对抗生素普拉地米星 - 贝纳诺霉素家族的生物合成途径进行了研究。向西奈芬净中添加菌株E - 40、产生普拉地米星A苷元的突变体或菌株AB1236会抑制11 - O - 去甲基 - 7 - 甲氧基普拉地酮II(11dM - 7M - PN II)的形成,导致11 - O - 去甲基普拉地米酮II和普拉地米酮II的积累。通过向在普拉地米星或贝纳诺霉素生物合成早期被阻断的突变体中投喂普拉地米星A苷元及其类似物,得到了以下结果:11 - O - 去甲基普拉地酮II、11dM - 7M - PN II、11 - O - 去甲基普拉地酮I、11 - O - 去甲基普拉地米酮I和普拉地米酮I被转化为普拉地米星A或贝纳诺霉素A;其余6种苷元类似物未被整合到抗生素中。普拉地米星B、葡糖基普拉地米星C和葡糖基贝纳诺霉素A分别被转化为普拉地米星A、普拉地米星C和贝纳诺霉素A。提出了这些抗生素的生物合成途径。